ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSK Gsk Plc

1,733.50
5.00 (0.29%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 0.29% 1,733.50 1,732.50 1,733.00 1,739.50 1,724.50 1,733.00 4,237,056 16:35:18
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.48 71.35B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,728.50p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,739.50p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £71.35 billion. Gsk has a price to earnings ratio (PE ratio) of 14.48.

Gsk Share Discussion Threads

Showing 31551 to 31571 of 33150 messages
Chat Pages: Latest  1266  1265  1264  1263  1262  1261  1260  1259  1258  1257  1256  1255  Older
DateSubjectAuthorDiscuss
28/12/2022
20:00
Hopefully 2023 will be a good year for gak sp
alibizzle
25/12/2022
09:49
Let's just use this thread?
tradermichael
24/12/2022
16:41
GlaxoSmithKline – defensive attractions
The pharmaceutical sector tends to offer defensive attractions as doctors and patients are always in need of the companies’ products, regardless of the machinations of the worldwide economy.

Shares in GlaxoSmithKline recently got a shot in the arm after a US judge threw out 2,500 major lawsuits that claimed its heartburn drug Zantac caused cancer. Analysts at broker Morgan Stanley had been concerned that the issue could have cost the company $45 billion in compensation claims. While there is still the possibility of individual lawsuits against Glaxo, this ruling ends a substantial concern for investors and a major overhang on the shares.

bountyhunter
24/12/2022
16:15
Q3 dividend pays out on 12 January 2023. Not long now ;o)
tradermichael
24/12/2022
12:52
I have every confidence in GSK’s future prospects and turnaround strategy buy buy buy!
paul planet earth
24/12/2022
01:16
Merry Xmas cya Wednesday
letsdothis
23/12/2022
21:44
GSK is a Shares Mag tip for 2023
bountyhunter
23/12/2022
13:22
Another twonk appears.. wonder if there is a limit to my filter list? ;)
rikky72
23/12/2022
12:07
Wishing you all a merry Xmas From the shorts & the BOILER ROOM exposing team enjoy your holidays & remember family is the most important thing EVER money is EASY to replace family can't be replaced WITH NO AMOUNT OF MONEY
letsdothis
23/12/2022
11:50
I would advise to be MEGA CARFUL
letsdothis
23/12/2022
11:50
BANKRUPTCY could loom
letsdothis
23/12/2022
11:50
I think that many law claims being made will GSK be able to survive after 6 months ?
letsdothis
23/12/2022
11:49
Being SUED LEFT RIGHT & centre
letsdothis
23/12/2022
11:49
Hence they have got some many liable claims being made
letsdothis
23/12/2022
11:34
Troll alert
alibizzle
23/12/2022
11:28
STOP LYING NO TAKE OVER PEOPLE THESE ARE BOILER ROOM SCUM IGNORE THEM IL EXPLAIN IF YOU GOOGLE A "stock boiler room" you will see what these people do Now use your brain this is about to CRASH they have had terrible results & a new law suit case opened how will they win ? There is 200,568 new cases of claims being filed as we speak this is going to TANK GOOD LUCK HOLDING A FALLING KNIFE
letsdothis
23/12/2022
11:23
>>which already started a while back>>

Evidence?

zho
23/12/2022
11:21
HLN Takeover only once Pfizer and GSK exit their holdings which already started a while back will take time though admittedly.
paul planet earth
22/12/2022
12:59
If HLN keeps going up (perhaps a takeover etc etc) doesn't that mean GSKs investment in HLN on its balance sheet automatically becomes worth more?
netcurtains
22/12/2022
10:35
21 Dec 22: VidPrevtyn Beta COVID-19 booster vaccine, developed by Sanofi and GSK, approved for use in Great Britain

SARS-CoV-2 spike protein (B.1.351 strain) vaccine is the first and only protein-based variant COVID-19 booster vaccine approved in Great Britain and the European Union
Results show the SARS-CoV-2 spike protein (B.1.351 strain) vaccine demonstrated an immune response against all tested variants of concern.

tradermichael
20/12/2022
13:41
Good haul of dividends, though (especially when you compound the return with re-purchase of shares at the lower prices)!
tradermichael
Chat Pages: Latest  1266  1265  1264  1263  1262  1261  1260  1259  1258  1257  1256  1255  Older

Your Recent History

Delayed Upgrade Clock